Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The evolution of antiplatelet therapy in cardiovascular disease.

Yousuf O, Bhatt DL.

Nat Rev Cardiol. 2011 Jul 12;8(10):547-59. doi: 10.1038/nrcardio.2011.96. Review.

PMID:
21750497
2.

Clinical use of clopidogrel.

Sarafoff N, Byrne RA, Sibbing D.

Curr Pharm Des. 2012;18(33):5224-39. Review.

PMID:
22724411
3.

Response variability to P2Y12 receptor inhibitors: expectations and reality.

Siller-Matula JM, Trenk D, Schrör K, Gawaz M, Kristensen SD, Storey RF, Huber K; EPA (European Platelet Academy).

JACC Cardiovasc Interv. 2013 Nov;6(11):1111-28. doi: 10.1016/j.jcin.2013.06.011. Review.

4.

Emerging antiplatelet therapy for coronary artery disease and acute coronary syndrome.

Packard KA, Campbell JA, Knezevich JT, Davis EM.

Pharmacotherapy. 2012 Mar;32(3):244-73. doi: 10.1002/j.1875-9114.2012.01021.x. Review.

PMID:
22392457
5.

The state of periprocedural antiplatelet therapy after recent trials.

Desai NR, Bhatt DL.

JACC Cardiovasc Interv. 2010 Jun;3(6):571-83. doi: 10.1016/j.jcin.2010.04.008. Review.

6.

Novel platelet ADP P2Y12 inhibitors in the treatment of acute coronary syndrome.

Tan GM, Lam YY, Yan BP.

Cardiovasc Ther. 2012 Aug;30(4):e167-73. doi: 10.1111/j.1755-5922.2011.00262.x. Epub 2011 Jul 31. Review.

PMID:
21883998
7.

Current Status of Antiplatelet Therapy in Acute Coronary Syndrome.

Dash D.

Cardiovasc Hematol Agents Med Chem. 2015;13(1):40-9. Review.

PMID:
26245659
8.

Antiplatelet drugs: which targets for which treatments?

Gachet C.

J Thromb Haemost. 2015 Jun;13 Suppl 1:S313-22. doi: 10.1111/jth.12947. Review.

9.

Antiplatelet therapy prasugrel: a novel platelet ADP P2Y12 receptor antagonist.

Mousa SA, Jeske WP, Fareed J.

Clin Appl Thromb Hemost. 2010 Apr;16(2):170-6. doi: 10.1177/1076029609355589. Review.

PMID:
20299391
10.
11.

New antiplatelet therapies in development.

Price MJ.

Am J Health Syst Pharm. 2008 Jul 1;65(13 Suppl 5):S11-5; quiz S16-8. doi: 10.2146/ajhp080157.

PMID:
18574020
12.

New anti-platelet agents: the end of resistance?

Kastrati A.

Thromb Res. 2012 Oct;130 Suppl 1:S53-5. doi: 10.1016/j.thromres.2012.08.275. Review.

PMID:
23026663
13.

Evolving role of platelet function testing in coronary artery interventions.

Sharma RK, Voelker DJ, Sharma R, Reddy HK, Dod H, Marsh JD.

Vasc Health Risk Manag. 2012;8:65-75. doi: 10.2147/VHRM.S28090. Epub 2012 Feb 8. Review.

14.

Current options in oral antiplatelet strategies during percutaneous coronary interventions.

Tantry US, Gurbel PA.

Rev Cardiovasc Med. 2011;12 Suppl 1:S4-13. Review.

PMID:
22080986
15.

A model-based analysis of the clinical and economic impact of personalising P2Y12-receptor inhibition with platelet function testing in acute coronary syndrome patients.

Straub N, Beivers A, Lenk E, Aradi D, Sibbing D.

Thromb Haemost. 2014 Feb;111(2):290-9. doi: 10.1160/TH13-08-0679. Epub 2013 Oct 24.

PMID:
24154566
16.

Pharmacological inhibition of platelet reactivity. Clinical and pharmacodynamic effects.

Vallés J, Moscardo A, Madrid I, Santos MT.

Curr Vasc Pharmacol. 2013 Jul;11(4):431-47. Review.

PMID:
23905638
17.

Optimizing antiplatelet therapy following percutaneous coronary intervention: clinical pathways for platelet function testing.

Lassar TA, Simon DI, Croce K.

Rev Cardiovasc Med. 2011;12 Suppl 1:S23-33. Review.

PMID:
22080984
18.

Platelet adenosine diphosphate receptor antagonists: ticlopidine to ticagrelor-a long continuing journey.

Kaul U, Mansoor AH.

Indian Heart J. 2012 Jan-Feb;64(1):54-9. doi: 10.1016/S0019-4832(12)60012-1. Epub 2012 Mar 26. Review.

19.

Updates in antiplatelet agents used in cardiovascular diseases.

Cheng JW.

J Cardiovasc Pharmacol Ther. 2013 Nov;18(6):514-24. doi: 10.1177/1074248413499971. Review.

PMID:
24213473
20.

Combined antiplatelet therapy: still a sweeping combination in cardiology.

Manolis AS, Manolis TA, Papadimitriou P, Koulouris S, Melita H.

Cardiovasc Hematol Agents Med Chem. 2013 Jun;11(2):136-67. Review.

PMID:
23597106

Supplemental Content

Support Center